Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2013 Jul 25;2013:bcr2013009911. doi: 10.1136/bcr-2013-009911

Gestational hypertrophy of the breast

Akshay Anand Agarwal 1, Abhinav Arun Sonkar 1, Jitendra Kumar Kushwaha 1, Suyash Singh 1
PMCID: PMC3736263  PMID: 23887986

Description

A 22-year-old woman, parity 1, 24 weeks pregnant, presented with massive diffuse enlargement of both breasts, since, second trimester. Her earlier pregnancy was uneventful. Multiple ulcerations as a result of pressure necrosis were also present for the last 3–4 months (figure 1). Her breasts were normal on ultrasonography with no evidence of cancer. Fine-needle aspiration revealed hyperplasia of the mammary glands with foci of increased fat and connective tissue. The patient was managed conservatively with antibiotics and dressings and she improved. The ulcerations and the huge size were affecting the morbidity of the patient. The patient was advised to have an abortion followed by reduction mammoplasty but she refused and has not since returned for follow up.

Figure 1.

Figure 1

A 22-year-old woman presented with massive diffuse enlargement of both breasts, since, second trimester with multiple ulcerations as a result of pressure necrosis.

Benign breast hypertrophy is a rare disorder; 1:28 000–1:100 0001 seems to occur only in adolescence and pregnancy. The aetiology remains unknown, but various theories have been put forward ranging from endocrine imbalance including hyperprolactinemia to target organ hypersensitivity.1 Histology of affected breast ranges from increase in the periductal interlobular connective tissue progressing to moderate lymphocytic infiltration of the hyaline connective tissue with significant lobular hypertrophy, ductal proliferation and periductal fibrosis consistent with changes found in normal breast. The enlargement may be associated with ulceration of the skin or sepsis or bleeding from the grossly engorged veins.

Some degree of regression occurs after delivery. Conservative management includes tamoxifen, testosterone, dihydrogestrone, hydrocortisone, diuretics and medroxy progesterone acetate, some patient may respond to bromocriptine therapy but this might not necessarily lead to regression of size. Suppression of lactation in the puerperium is mandatory, as further engorgement may precipitate infection and necrosis. Surgical treatments include reduction mammoplasty, subcutaneous mastectomy or total mastectomy with reconstruction of nipple areola complex forms the mainstay of treatment.2 Termination of pregnancy in first trimester may be needed if the skin overlying the enlarged breast gets severely ulcerated and necrosed. Less often bilateral mastectomies may also be needed.3

Learning points.

  • Cause of gigantomastia is unknown.

  • The patient may have varied response to bromocriptine therapy or any other medical therapy ultimately necessitating surgical intervention.

  • Giant fibroadenoma, phylloides tumour of the breast, non-Hodgkin lymphoma and lymphoblastic lymphoma may form differential diagnosis.

Acknowledgments

The authors would like to acknowledge Dr Yaduvendra Dheer, Dr Ashish Singh, Dr Kushagra Gaurav and Dr Prathna Saxena.

Footnotes

Contributors: All authors have contributed in finding literature, writing the manuscript and reviewing it.

Competing interests: None.

Patient consent: Obtained.

Provenance and peer review: Not commissioned; externally peer reviewed.

References

  • 1.Agrawal N, Kriplani A, Gupta A. Management of gigantomastia complicating pregnancy. A case report. J Reprod Med 2002;2013:871–4 [PubMed] [Google Scholar]
  • 2.El Boghdadly S, Pitkam J, Hassonab M. Emergency mastectomy in gigantomastia of pregnancy : a case report and review literature. Ann Saudi Med 1997;2013:220–2. [DOI] [PubMed] [Google Scholar]
  • 3.Antveski BM, Smilevski DA, Stojovski MZ, et al. Extreme gigantomastia in pregnancy: case report and review of literature. Arch Gynecol Obstet 2007;2013:149–53 [DOI] [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES